Year: 2026

VenHub enters the Florida market through a new operator-led deployment model, marking a key step in its U.S. commercial rollout LAS VEGAS, June 09, 2026 (GLOBE NEWSWIRE) — VenHub Global, Inc. (NASDAQ: VHUB) (“VenHub” or the “Company”), a leader in fully autonomous Smart Store technology, today announced its expansion into the Florida market through a new commercial deployment with a local operator. The initial rollout will target the Tampa Bay region, representing VenHub’s first “Powered by VenHub” presence in the state. The expansion reflects VenHub’s broader commercial strategy of enabling local operators to deploy and brand autonomous retail locations using its fully integrated infrastructure platform, bringing enterprise-grade retail technology to high-traffic environments without the labor overhead, shrinkage exposure, or...

– BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham  – Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma – Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers – Elraglusib has received FDA Rare Pediatric Disease designation for neuroblastoma CHICAGO and FORT WORTH, Texas, June 09, 2026 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU), a clinical-stage biopharmaceutical company focused on developing novel therapies for difficult-to-treat cancers, today announced that elraglusib will be evaluated in the BEACON2 clinical...

VANCOUVER, British Columbia, June 09, 2026 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, today announces the company been added as a member of the broad-market Russell 3000® Index effective at market open on June 29, 2026, as part of the first 2026 Russell indexes reconstitution. The inclusion reflects ZenaTech’s continued growth and market capitalization and is expected to broaden the Company’s credibility and exposure to investors, including institutional investors, ETFs, and index funds that track Russell small-cap companies. “Being added to the Russell 3000® Index is a significant achievement for ZenaTech and...

SINGAPORE, June 09, 2026 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited Bitcoin production and operational metrics for May 2026. “In May, BitFuFu delivered strong operational results with total Bitcoin production rising 22.1% month-over-month to 177 BTC. The more significant story, however, was the strategic shift in our production mix: self-mining output nearly tripled to 90 BTC in May from 32 BTC in April and accounted for more than half of total production. This reflects a deliberate capital allocation decision. We view the current Bitcoin price environment as an attractive long-term accumulation opportunity, and we have proactively shifted resources toward self-mining to build our Bitcoin holdings. We remain...

Milestone Demonstrates Viability of PureCycle’s Recycled Resin in High-Performance Flexible Packaging for Snack, Confectionery and Roll-Fed Label Applications ORLANDO, Fla., June 09, 2026 (GLOBE NEWSWIRE) — PureCycle Technologies, Inc. (Nasdaq: PCT), today announced the successful production and trial evaluation of white, cavitated biaxially oriented polypropylene (BOPP) film in collaboration with Innovia Films, a leading material science pioneer and global manufacturer of packaging, graphics and label films. The film was produced using PureCycle’s PureFive Choice™ resin, and the film contains more than 40% post-consumer recycled (PCR) content. This film will be marketed to brand owners interested in introducing recycled content to their own white, cavitated BOPP applications.  White, cavitated BOPP film is a critical...

To Nasdaq Copenhagen A/S                                                                              June 9, 2026                                         Announcement No. 48/2026 Notice of Extraordinary General Meeting of Jyske Realkredit A/S on Thursday, June 25, 2026, at 7:30 a.m. at the company’s address: Kalvebod Brygge 3, 1560 Copenhagen V. Agenda for consideration and final adoption It is proposed that annual reports may be prepared in English, and accordingly, an amendment to the Articles of Association must be adopted pursuant to Art.100a of the Danish Companies Act if the general meeting approves the proposal.Proposed amendment to the Articles of Association: Art. 12, new (2): “Annual reports shall be prepared and presented in English. The Supervisory Board may determine that annual reports shall also be prepared in Danish.” Motion...

Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatment, with Decline in Severe Functional Impairment from 85% to 0% BURLINGTON, Mass. and JERUSALEM, June 09, 2026 (GLOBE NEWSWIRE) — BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the presentation of new prospective 12-month durability data demonstrating sustained clinical benefits following accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Major Depressive Disorder (MDD). The findings were recently presented in a poster by Colleen Hanlon, PhD, Vice President of Medical Affairs for BrainsWay, at the 14th Annual Clinical TMS Society (CTMSS) Meeting which was held on June 4-6, 2026. The data represented outcomes from the first multisite,...

LOUISVILLE, Ky., June 09, 2026 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced that it will be added to the Russell 3000® Index effective when the US market opens on June 29, 2026, as part of the Russell indexes reconstitution. The June reconstitution captures up to the 4,000 largest US stocks as of April 30, ranked by total market capitalization. Membership in the Russell 3000® Index, which remains in place for half a year, also means automatic inclusion in the small-cap Russell 2000® Index as well as the appropriate growth and value-style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization...

MINNEAPOLIS, June 09, 2026 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Jared Oasheim, the Company’s Chief Financial Officer, will be stepping down from his role to pursue other professional opportunities. To support a seamless transition, Mr. Oasheim will remain with the Company until a successor is appointed and remain available as an advisor through February 2027. “Jared has been an integral part of CVRx since 2015, and has made a lasting mark on our company over the past decade” said Kevin Hykes, President and Chief Executive Officer of CVRx. “He led CVRx through its initial public offering and built the disciplined finance...

WASHINGTON, June 09, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of former healthcare executive Sean O’Reilly as a Senior Managing Director in the firm’s Healthcare Risk Management & Advisory practice. Mr. O’Reilly brings more than 25 years of experience advising healthcare organizations on compliance program design, regulatory risk management and operational integrity across a range of healthcare sectors, including Medicare Advantage, Medicaid, employer group medical and specialty insurance, military healthcare, hospice, home health, value-based primary care and pharmacy. In his role at FTI Consulting, Mr. O’Reilly will advise clients on the design, implementation and improvement of enterprise compliance programs, focusing on risk identification, control development and regulatory...